Literature DB >> 19175143

Comparison of two-dimensional and three-dimensional iterative watershed segmentation methods in hepatic tumor volumetrics.

Shonket Ray1, Rosalie Hagge, Marijo Gillen, Miguel Cerejo, Shidrokh Shakeri, Laurel Beckett, Tamara Greasby, Ramsey D Badawi.   

Abstract

In this work the authors compare the accuracy of two-dimensional (2D) and three-dimensional (3D) implementations of a computer-aided image segmentation method to that of physician observers (using manual outlining) for volume measurements of liver tumors visualized with diagnostic contrast-enhanced and PET/CT-based non-contrast-enhanced (PET-CT) CT scans. The method assessed is a hybridization of the watershed method using observer-set markers with a gradient vector flow approach. This method is known as the iterative watershed segmentation (IWS) method. Initial assessments are performed using software phantoms that model a range of tumor shapes, noise levels, and noise qualities. IWS is then applied to CT image sets of patients with identified hepatic tumors and compared to the physicians' manual outlines on the same tumors. The repeatability of the physicians' measurements is also assessed. IWS utilizes multiple levels of segmentation performed with the use of "fuzzy regions" that could be considered part of a selected tumor. In phantom studies, the outermost volume outline for level 1 (called level 1_1 consisting of inner region plus fuzzy region) was generally the most accurate. For in vivo studies, the level 1_1 and the second outermost outline for level 2 (called level 2_2 consisting of inner region plus two fuzzy regions) typically had the smallest percent error values when compared to physician observer volume estimates. Our data indicate that allowing the operator to choose the "best result" level iteration outline from all generated outlines would likely give the more accurate volume for a given tumor rather than automatically choosing a particular level iteration outline. The preliminary in vivo results indicate that 2D-IWS is likely to be more accurate than 3D-IWS in relation to the observer volume estimates.

Entities:  

Mesh:

Year:  2008        PMID: 19175143      PMCID: PMC2673614          DOI: 10.1118/1.3013561

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  29 in total

1.  Determination of the presampled MTF in computed tomography.

Authors:  J M Boone
Journal:  Med Phys       Date:  2001-03       Impact factor: 4.071

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Shape-constraint region growing for delineation of hepatic metastases on contrast-enhanced computed tomograph scans.

Authors:  Binsheng Zhao; Lawrence H Schwartz; Li Jiang; Jane Colville; Chaya Moskowitz; Liang Wang; Robert Leftowitz; Fan Liu; John Kalaigian
Journal:  Invest Radiol       Date:  2006-10       Impact factor: 6.016

4.  A fuzzy c-means (FCM)-based approach for computerized segmentation of breast lesions in dynamic contrast-enhanced MR images.

Authors:  Weijie Chen; Maryellen L Giger; Ulrich Bick
Journal:  Acad Radiol       Date:  2006-01       Impact factor: 3.173

5.  Volumetric analysis of liver metastases in computed tomography with the fuzzy C-means algorithm.

Authors:  Peter J Yim; Amit V Vora; Deepak Raghavan; Ravi Prasad; Matthew McAullife; Pamela Ohman-Strickland; John L Nosher
Journal:  J Comput Assist Tomogr       Date:  2006 Mar-Apr       Impact factor: 1.826

6.  Snakes, shapes, and gradient vector flow.

Authors:  C Xu; J L Prince
Journal:  IEEE Trans Image Process       Date:  1998       Impact factor: 10.856

7.  The effect of measuring error on the results of therapeutic trials in advanced cancer.

Authors:  C G Moertel; J A Hanley
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

8.  Pulmonary metastases: effect of CT section thickness on measurement--initial experience.

Authors:  Binsheng Zhao; Lawrence H Schwartz; Chaya S Moskowitz; Liang Wang; Michelle S Ginsberg; Cathleen A Cooper; Li Jiang; John P Kalaigian
Journal:  Radiology       Date:  2005-01-28       Impact factor: 11.105

9.  A new fully automatic and robust algorithm for fast segmentation of liver tissue and tumors from CT scans.

Authors:  Laurent Massoptier; Sergio Casciaro
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

Review 10.  Molecular insights into cancer invasion: strategies for prevention and intervention.

Authors:  E C Kohn; L A Liotta
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

View more
  9 in total

1.  Treatment planning and volumetric response assessment for Yttrium-90 radioembolization: semiautomated determination of liver volume and volume of tumor necrosis in patients with hepatic malignancy.

Authors:  Wayne L Monsky; Armando S Garza; Isaac Kim; Shaun Loh; Tzu-Chun Lin; Chin-Shang Li; Jerron Fisher; Parmbir Sandhu; Vishal Sidhar; Abhijit J Chaudhari; Frank Lin; Larry-Stuart Deutsch; Ramsey D Badawi
Journal:  Cardiovasc Intervent Radiol       Date:  2010-08-04       Impact factor: 2.740

2.  Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.

Authors:  Zhijun Wang; Julius Chapiro; Rüdiger Schernthaner; Rafael Duran; Rongxin Chen; Jean-François Geschwind; MingDe Lin
Journal:  Acad Radiol       Date:  2015-04-08       Impact factor: 3.173

3.  Liver tumour segmentation using contrast-enhanced multi-detector CT data: performance benchmarking of three semiautomated methods.

Authors:  Jia-Yin Zhou; Damon W K Wong; Feng Ding; Sudhakar K Venkatesh; Qi Tian; Ying-Yi Qi; Wei Xiong; Jimmy J Liu; Wee-Kheng Leow
Journal:  Eur Radiol       Date:  2010-02-16       Impact factor: 5.315

4.  Automated noninvasive classification of renal cancer on multiphase CT.

Authors:  Marius George Linguraru; Shijun Wang; Furhawn Shah; Rabindra Gautam; James Peterson; W Marston Linehan; Ronald M Summers
Journal:  Med Phys       Date:  2011-10       Impact factor: 4.071

5.  Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI.

Authors:  Wayne L Monsky; Bedro Jin; Chris Molloy; Robert J Canter; Chin Shang Li; Tzu C Lin; Daniel Borys; Walter Mack; Isaac Kim; Michael H Buonocore; Abhijit J Chaudhari
Journal:  Anticancer Res       Date:  2012-11       Impact factor: 2.480

6.  Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.

Authors:  Farnaz Najmi Varzaneh; Ankur Pandey; Mounes Aliyari Ghasabeh; Nannan Shao; Pegah Khoshpouri; Pallavi Pandey; Manijeh Zarghampour; Daniel Fouladi; Robert Liddell; Robert Albert Anders; Ihab R Kamel
Journal:  Eur Radiol       Date:  2018-01-30       Impact factor: 5.315

7.  Comparison of semi-automatic volumetric VX2 hepatic tumor segmentation from cone beam CT and multi-detector CT with histology in rabbit models.

Authors:  Olivier Pellerin; Mingde Lin; Nikhil Bhagat; Roberto Ardon; Benoit Mory; Jean-François Geschwind
Journal:  Acad Radiol       Date:  2012-09-02       Impact factor: 3.173

Review 8.  How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health.

Authors:  Vladimir Kuznetsov; Hwee Kuan Lee; Sebastian Maurer-Stroh; Maria Judit Molnár; Sandor Pongor; Birgit Eisenhaber; Frank Eisenhaber
Journal:  Health Inf Sci Syst       Date:  2013-01-10

9.  A novel phantom technique for evaluating the performance of PET auto-segmentation methods in delineating heterogeneous and irregular lesions.

Authors:  B Berthon; C Marshall; R Holmes; E Spezi
Journal:  EJNMMI Phys       Date:  2015-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.